Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · refreshes every 15s during session
Limited proprietary earnings coverage for ALLR yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 22d ago
ALLR's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on ALLR.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Allarity Therapeutics, Inc. (ALLR) — events, not interpretation.
Research & analysis only — not investment advice.
AlphaOS industries
Investment snapshot
ALLR's AI investment thesis
Upgrade to Premium for ALLR's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Latest price
$1.03
Market cap
$16.39M
Profitable
No
Net income
$-11.23M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Allarity Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Allarity Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.